EPDA signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Prep: Cook: Serves:

The European Parkinson’s Disease Association (EPDA) has signed the Dying to Work Charter – a pledge protecting the workplace rights of people with serious conditions.

The charter – part of the Trade Union Congress’ wider Dying to Work campaign – has so far protected over half a million workers in the UK.

The Dying to Work campaign group, chaired by MEP Rory Palmer, is calling on the European Union to amend its current legislation.

The campaign is asking for serious conditions to be identified as a ‘protected characteristic’ – meaning employees would enjoy a protected period after diagnosis which would ensure the couldn’t be unfairly dismissed.

Russell Patten, secretary general at the EPDA, said: “At the EPDA, we are committed to improving employment conditions, reducing stigma and ensuring accessibility to essential services for all people with Parkinson’s disease.”

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at the EPDA (right).

To support the charter, please click here.

For more information on working with Parkinson’s please visit the EPDA website.

Could robots replace animals in Parkinson’s medical trials?

Last Month

Next Month

Go Back

Share this story

Comments

Advances

The students breaking ground in Parkinson’s tech

An app that’s digitising the spiral test

“Nobody ever thought I had Parkinson’s disease – I was just 10 years old”

How one girl has coped with Parkinson's since she was 10

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

A look at the rare conditions often mistaken for Parkinson’s

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

A new study reprogramming cells to replace reduced dopamine neurons in the brain could be used to reverse symptoms of Parkinson’s and other neurological conditions. As part of the study – conducted by the University of California San Diego (UCSD) – researchers found a way to convert star-shaped brain cells called astrocytes into cells producing dopamine. The team used the method to treat mouse models of Parkinson’s, administering the treatment into the areas of the brain that typically lose dopamine producing neurons. This restored reduced dopamine production to normal levels and reversed the symptoms of Parkinson’s. The researchers will continue to optimise the therapy in other mouse models of Parkinson’s before testing it on people with the condition. William Mobley, a neurosciences professor at UCSD, said: “I was stunned at what I saw. This whole new strategy for treating neurodegeneration gives hope that it may be possible to help even…

Could a magnetically powered implant treat Parkinson’s tremors?

A tiny surgical implant about the size of a grain of rice that can be implanted with minimally invasive surgery may be used to treat tremors in people with Parkinson’s. Developed by a team of researchers at Rice University, US, the implant uses a thin film of magnetoelectric material to convert acoustic waves from the brain’s magnetic field into electrical voltage. The device produces the same high-frequency signals as clinically approved implants used to treat Parkinson’s, epilepsy and other conditions – and eliminates the need for battery or wired power supply. In an initial study, the researchers showed that the implants worked in rodents. Professor Jacob Robinson, corresponding author of the study, said: “Our results suggest that using magnetoelectric materials for wireless power delivery is more than a novel idea. These materials are excellent candidates for clinical-grade, wireless bioelectronics.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

EPDA signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Prep: Cook: Serves:

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at the EPDA (right).

Last Month

Next Month

Share this story

Comments

Advances

The students breaking ground in Parkinson’s tech

Perspectives

“Nobody ever thought I had Parkinson’s disease – I was just 10 years old”

Resources & Tools

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

{title}

Subscribe

EPDA signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Prep: Cook: Serves:

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at the EPDA (right).

Last Month

Next Month

Share this story

Comments

Related articles

Advances

The students breaking ground in Parkinson’s tech

Perspectives

“Nobody ever thought I had Parkinson’s disease – I was just 10 years old”

Resources & Tools

Parkinson’s podcast: ‘Parkinson’s Plus’ conditions

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

{title}

Subscribe

Sign in